Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the basis of partnerships with big pharma and lead to the formation of new biotech companies — all focused on common diseases…

science

Sources